Interní Med. 2010; 12(3): 152-154

Primary headache

MUDr.Jiří Mastík
Neurologická klinika FN U Sv. Anny, Brno

International Classification of Headache Disorders recognizes primary and secondary type of headache. Primary headache has no

underlying organic or structural laesion and all the clinical investigations are normal. There are three main types of primary headache –

migraine, cluster headache and other trigeminal autonomic cephalalgias and tension-type headache and each has its specific treatment.

Secondary headache has its uderlying condition, either organic or structural intra-/extra-cerebral laesions or dysbalance of homeostasis

or administration/whithdrawal of various chemical agents. It is essential to differentiate between primary and secondary headache.

Keywords: primary headache, migraine, secondary headache, treatment, diagnostics

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mastík J. Primary headache. Interní Med. 2010;12(3):152-154.
Download citation

References

  1. Headache Classification Subcommittee of the International Headache Society. The International Classification and diagnostic criteria of headache disorders. 2nd edition. Cephalalgia, 2004; 24(Suppl.1): 160 s.
  2. Opavský J, Keller O, Kotas R, et al. Česká verze revidované Mezinárodní klasifikace bolestí hlavy (ICHD - II) navržené a předložené Mezinárodní společností pro bolesti hlavy. Čes Slov Neurol Neurochir, 2005; 68/101(2): 133-138.
  3. Kotas R. Primární nebo sekundární bolest hlavy? Bolest 2009; 2: 73-77.
  4. Marková J, Mastík J, Waberžinek G. Bolesti hlavy. Stručné zásady diagnostiky a léčby. Maxdorf, Mediforum 2003. 18 s.
  5. Mastík J. Migréna. Praha: Maxdorf 2007: 104 s.
  6. Silberstein SD, Lipton RB, Dalessio DJ. Wolff´s Headache and other head pain. 7th edition. Oxford University Press, New York 2001. 625 s.
  7. Diener HC. Migréna (Migräne, dritte völlig). Scientia Medica, Praha 1994. 84 s.
  8. Silberstein SD, Diener HC. Clinician´s manual on migraine. Current Medicine Group. London, 2006: 58 s.
  9. Kotas R, a kol. Migréna. Patofyziologie a léčba. Maxdorf, Praha 2001. 195 s.
  10. Mathew NT. Transformed migraine. Cephalalgia 1993; 13 (Suppl 12): 78-83. Go to original source... Go to PubMed...
  11. Géraud G, Kenwood C, Senard JM. Migraine headache recurrence: relationship to clinical, pharmacological and pharmacokinetic properties of triptans. Headache 2003; 43: 376-388. Go to original source... Go to PubMed...
  12. Mastík J. Migréna - Nová mezinárodní klasifikace a moderní léčebné postupy. Neurol Pro Praxi 2005; 1: 28-31.
  13. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonisty) in acute migraine treatment: a metaanalysis of 53 trials. Lancet 2001; 358: 1668-1675. Go to original source... Go to PubMed...
  14. Diener HC. Pharmacological approaches to migraine. J Neural Transm 2003; 64(Suppl): 35-63. Go to original source... Go to PubMed...
  15. Waberžinek G. Migréna - diagnostika a léčba. Triton, Praha 2003, 158 s.
  16. Niedermayerová I, Mastík J. Lisinopril je účinný v profylaxi migrény. Practicus, 2007; 5-6: 200-203.
  17. Langemark M, Olesen J, Poulsen DL, Bech P. Clinical characteristics of patients with tension-type headache. Headache 1988; 28: 590-596. Go to original source... Go to PubMed...
  18. Torelli P, Cologno D, Cademartiri C, Manzoni GC. Application of the International headache society classification criteria in 652 cluster headache patients. Cephalalgia 2001; 21: 145-150. Go to original source... Go to PubMed...
  19. Doležil D, Peisker T, Doležilová V, et al. Thunderclap headache. In press 2010.
  20. Silberstein SD, Stiles MA, Young WB. Atlas of Migraine and other headaches. 2nd edition. Taylor and Francis, London, New York 2005. Go to original source...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.